Expert Guidance on Multidisciplinary Management of CAR T-Cell Toxicities

In this expert-authored downloadable slideset, review the biologic principles underlying toxicities associated with CAR T-cell therapy and how to leverage multidisciplinary strategies to manage these unique adverse events.
Matthew J. Frigault, MD
Program Director
Format: Microsoft PowerPoint (.ppt)
File Size: 1.49 MB
Released: May 17, 2019


Provided by
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)

Supported by educational grants from
Celgene Corporation
Kite, A GILEAD Company

Related Content

John M. Burke, MD, and Shaji Kumar, MD, discuss practice-changing presentations in lymphomas, CLL, and multiple myeloma from ASCO 2019.

John M. Burke, MD Shaji Kumar, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: August 16, 2019 Expiration: August 15, 2020

Noopur Raje, MD: Clinical impact of latest data for idecabtagene vicleucel (bb2121) and other CAR T-cells in relapsed/refractory multiple myeloma.

Noopur Raje, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 16, 2019 Expiration: August 15, 2020

A CME-certified activity with insights on the optimal care of advanced gastric/GEJ cancers using checkpoint inhibitors from Clinical Care Options

Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP Axel Grothey Headshot Axel Grothey, MD Steven Maron, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: August 9, 2019 Expiration: August 8, 2020

This archived CCO symposium Webcast provides expert guidance on the use of immune checkpoint inhibitors in advanced head and neck cancers (HNSCC)

Barbara Ann Burtness, MD
Program Director
Robert L. Ferris, MD, PhD Cristina P. Rodriguez, MD
Physicians: maximum of 2.0 AMA PRA Category 1 Credits Released: August 8, 2019 Expiration: August 7, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?